MYD88 and atherosclerosis: Collectively, these results indicate that inactivation of TLR4/MyD88-dependent signaling strongly inhibits development of atherosclerosis and promotes a more stable plaque phenotype, mainly by reducing inflammatory molecule release as a consequence of NF-κB inactivation.